Skip to content
Brand AI

Elusys Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2022

    NightHawk Biosciences completes acquisition of Elusys Therapeutics

    Heat Biologics, which said it was to be renamed NightHawk Biosciences, announced that it had completed its acquisition of Elusys Therapeutics, which became a wholly owned biodefense subsidiary.

    Source